Allogene Therapeutics ALLO
NASDAQ ALLO
$0.90 -0.03 (-3.41%)
At close: Nov 11, 2026 · 4:00 PM EST

Allogene Therapeutics (ALLO) Long-Term Debt Repayments (2018 - 2026)

Updated

Analysis

Allogene Therapeutics (ALLO) Long-Term Debt Repayments (2018 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 1.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -4.91 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 3.05 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 19.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Allogene Therapeutics 322.04 Mn -820.62 Mn - -3.29 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -3.29 Mn
Jun 30, 2026 -3.30 Mn
Mar 31, 2026 -3.23 Mn
Dec 31, 2025 -3.24 Mn
Sep 30, 2025 -3.17 Mn
Jun 30, 2025 -3.29 Mn
Mar 31, 2025 -3.23 Mn
Mar 31, 2024 -3.07 Mn
Dec 31, 2023 -3.04 Mn
Sep 30, 2023 -3.02 Mn
Jun 30, 2023 -3.02 Mn
Mar 31, 2023 -2.97 Mn
Dec 31, 2022 -2.94 Mn
Sep 30, 2022 -2.62 Mn
Jun 30, 2022 -2.00 Mn
Mar 31, 2022 -1.98 Mn
Dec 31, 2021 -1.96 Mn
Sep 30, 2021 -1.63 Mn
Jun 30, 2021 -1.47 Mn
Mar 31, 2021 -966,000.00
API Access

Allogene Therapeutics Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=ALLO&period=max&api_key=YOUR_API_KEY